과제정보
연구 과제 주관 기관 : Ministry of Health & Welfare
참고문헌
- Andres, V. and Castro, C. (2003) Antiproliferative strategies for the treatment of vascular proliferative disease. Curr. Vasc. Pharmacol. 1, 85-98 https://doi.org/10.2174/1570161033386763
- Chen, K., Thomas, S. R., and Keaney, J. F. Jr. (2003) Beyond LDL oxidation: ROS in vascular signal transduction. Free Radic. Biol. Med. 35, 117-132 https://doi.org/10.1016/S0891-5849(03)00239-9
- Cho, H. M., Choi, S. H., Hwang, K. C., Oh, S. Y., Kim, H. G., et al. (2005) The Src/PLC/PKC/MEK/ERK signaling pathway is involved in aortic smooth muscle cell proliferation induced by glycated LDL. Mol. Cells 19, 60-66
- Choi, S. H., Cho, S. K., Kang, S. S., Bae, C. S., Bai, Y. H., et al. (2003) Effect of apitherapy in piglets with preweaning diarrhea. Am. J. Chin. Med. 31, 321-326 https://doi.org/10.1142/S0192415X03001004
- Della Rocca, G. J., van Biesen, T., Daaka, Y., Luttrell, D. K., Luttrell, L. M., et al. (1997) Ras-dependent mitogenactivated protein kinase activation by G protein-coupled receptors. Convergence of Gi- and Gq-mediated pathways on calcium/calmodulin, Pyk2, and Src kinase. J. Biol. Chem. 272, 19125-19132 https://doi.org/10.1074/jbc.272.31.19125
- Gunther, S., Alexander, R. W., Atkinson, W. J., and Gimbrone, M. A. Jr. (1982) Functional angiotensin II receptors in cultured vascular smooth muscle cells. J. Cell Biol. 92, 289- 298 https://doi.org/10.1083/jcb.92.2.289
- Han, M. J., Kim, B. Y., Yoon, S. O., and Chung, A. S. (2003) Cell proliferation induced by reactive oxygen species is mediated via mitogen-activated protein kinase in chinese hamster lung fibroblast (V79) cells. Mol. Cells 15, 94-101
- Hong, Y., Hui, S. C., Chan, T. Y., and Hou, J. Y. (2002) Effect of berberine on regression of pressure-overload induced cardiac hypertrophy in rats. Am. J. Chin. Med. 30, 589-599 https://doi.org/10.1142/S0192415X02000612
- Iizuka, N., Oka, M., Yamamoto, K., Tangoku, A., Miyamoto, K., et al. (2003) Identification of common or distinct genes related to antitumor activities of a medicinal herb and its major component by oligonucleotide microarray. Int. J. Cancer 107, 666-672 https://doi.org/10.1002/ijc.11452
- Kang, D. G., Sohn, E. J., Kwon, E. K., Han, J. H., Oh, H., et al. (2002) Effects of berberine on angiotensin-converting enzyme and NO/cGMP system in vessels. Vascul. Pharmacol. 39, 281-286 https://doi.org/10.1016/S1537-1891(03)00005-3
- Kim, S. and Iwao, H. (2003) Stress and vascular responses: mitogen-activated protein kinases and activator protein-1 as promising therapeutic targets of vascular remodeling. J. Pharmacol. Sci. 91, 177-181 https://doi.org/10.1254/jphs.91.177
- Ko, W. H., Yao, X. Q., Lau, C. W., Law, W. I., Chen, Z. Y., et al. (2000) Vasorelaxant and antiproliferative effects of berberine. Eur. J. Pharmacol. 399, 187-196 https://doi.org/10.1016/S0014-2999(00)00339-3
- Kuo, C. L., Chi, C. W., and Liu, T. Y. (2004) The antiinflammatory potential of berberine in vitro and in vivo. Cancer Lett. 203, 127-137 https://doi.org/10.1016/j.canlet.2003.09.002
- Kohno, M., Yokokawa, K., Yasunari, K., Minami, M., Kano, H., et al. (1998) Induction by lysophosphatidylcholine, a major phospholipid component of atherogenic lipoproteins, of human coronary artery smooth muscle cell migration. Circulation 98, 353-359 https://doi.org/10.1161/01.CIR.98.4.353
- Kong, W., Wei, J., Abidi, P., Lin, M., Inaba, S., et al. (2004) Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat. Med. 10, 1344-1351 https://doi.org/10.1038/nm1135
- Kugiyama, K., Sugiyama, S., Ogata, N., Oka, H., Doi, H., et al. (1999) Burst production of superoxide anion in human endothelial cells by lysophosphatidylcholine. Atherosclerosis 143, 201-204 https://doi.org/10.1016/S0021-9150(98)00288-3
- Lau, C. W., Yao, X. Q., Chen, Z. Y., Ko, W. H., and Huang, Y. (2001) Cardiovascular actions of berberine. Cardiovasc. Drug Rev. 19, 234-244 https://doi.org/10.1111/j.1527-3466.2001.tb00068.x
- Law, R. E., Meehan, W. P., Xi, X. P., Graf, K., Wuthrich, D. A., et al. (1996) Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia. J. Clin. Invest. 98, 1897-1905 https://doi.org/10.1172/JCI118991
- Martindale, J. L. and Holbrook, N. J. (2002) Cellular response to oxidative stress: signaling for suicide and survival. J. Cell. Physiol. 192, 1-15 https://doi.org/10.1002/jcp.10119
- Rivard, A. and Andres, V. (2000) Vascular smooth muscle cell proliferation in the pathogenesis of atherosclerotic cardiovascular diseases. Histol. Histopathol. 15, 557-571
- Stermitz, F. R., Lorenz, P., Tawara, J. N., Zenewicz, L. A., and Lewis, K. (2000) Synergy in a medicinal plant: antimicrobial action of berberine potentiated by 5′-methoxyhydnocarpin, a multidrug pump inhibitor. Proc. Natl. Acad. Sci. USA 97, 1433-1437
- Suenaga, H. and Kamata, K. (2003) Lysophosphatidylcholine activates extracellular-signal-regulated protein kinase and potentiates vascular contractile responses in rat aorta. J. Pharmacol. Sci. 92, 348-358 https://doi.org/10.1254/jphs.92.348
- Takemoto, M. and Liao, J. K. (2001) Pleiotropic effects of 3- hydroxy-3-methylglutaryl coenzyme a reductase inhibitors. Arterioscler. Thromb. Vasc. Biol. 21, 1712-1719 https://doi.org/10.1161/hq1101.098486
- Tarpey, M. M. and Fridovich, I. (2001) Methods of detection of vascular reactive species: nitric oxide, superoxide, hydrogen peroxide, and peroxynitrite. Circ. Res. 89, 224-236 https://doi.org/10.1161/hh1501.094365
- Wartenberg, M., Budde, P., De Marees, M., Grunheck, F., Tsang, S. Y., et al. (2003) Inhibition of tumor-induced angiogenesis and matrix-metalloproteinase expression in confrontation cultures of embryoid bodies and tumor spheroids by plant ingredients used in traditional Chinese medicine. Lab. Invest. 83, 87-98
- Watanabe, T., Pakala, R., Katagiri, T., and Benedict, C. R. (2002) Lysophosphatidylcholine is a major contributor to the synergistic effect of mildly oxidized low-density lipoprotein with endothelin-1 on vascular smooth muscle cell proliferation. J. Cardiovasc. Pharmacol. 39, 449-459 https://doi.org/10.1097/00005344-200203000-00017
- Yamakawa, T., Eguchi, S., Yamakawa, Y., Motley, E. D., Numaguchi, K., et al. (1998) Lysophosphatidylcholine stimulates MAP kinase activity in rat vascular smooth muscle cells. Hypertension 31, 248-253 https://doi.org/10.1161/01.HYP.31.1.248
- Yamakawa, T., Tanaka, S., Yamakawa, Y., Kamei, J., Numaguchi, K., et al. (2002) Lysophosphatidylcholine activates extracellular signal-regulated kinases 1/2 through reactive oxygen species in rat vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 22, 752-758 https://doi.org/10.1161/01.ATV.0000015903.02749.71
- Yamakawa, T., Tanaka, S., Kamei, J., Kadonosono, K., and Okuda, K. (2003) Pitavastatin inhibits vascular smooth muscle cell proliferation by inactivating extracellular signalregulated kinases 1/2. J. Atheroscler. Thromb. 10, 37-42 https://doi.org/10.5551/jat.10.37
- Yla-Herttuala, S., Palinski, W., Rosenfeld, M. E., Parthasarathy, S., Carew, T. E., et al. (1989) Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J. Clin. Invest. 84, 1086-1095 https://doi.org/10.1172/JCI114271
- Zeng, X. H., Zeng, X. J., and Li, Y. Y. (2003) Efficacy and safety of berberine for congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am. J. Cardiol. 92, 173-176 https://doi.org/10.1016/S0002-9149(03)00533-2